Swiss Company to Provide Refund to US Consumers


October 10, 2005

Swiss Company to Provide Refund to US Consumers

Defendants Sold Worthless Products and Dietary Supplements to Cure Serious Diseases

FTC News Release
December 3, 2004

A Switzerland-based company and its United States counterpart have agreed to provide refunds to its US citizens, as part of a settlement with the Federal Trade Commission. Dr. Clark Research Association, a California company and Dr. Clark Behandlungszentrum GMbH, d/b/a Dr. Clark Zentrum, sold a variety of dietary supplements and devices that they alleged cured advanced and terminal cancers, AIDS, and other serious diseases. The FTC alleged that the defendants made unsubstantiated health or safety claims.

In its complaint, the FTC alleged that the defendants advertised, among other things, that:

  • the “Zapper” (sold as the “Super-Zapper Deluxe”) is a device that purportedly kills disease-causing parasites in the body with electricity and is effective in treating serious and chronic diseases like cancer and AIDS;
  • the “Syncrometer” is a device that purportedly can detect substances within the body and diagnose diseases;
  • “Dr. Clark’s New 21 Day Program for Advanced Cancers,” a regimen that includes dietary supplements, purportedly cures advanced cases of cancer and, when used with the “Super-Zapper Deluxe,” renders surgery and chemotherapy unnecessary; and
  • the “Complete Herbal Parasite Program” — also called the Herbal Parasite Cleanse — is effective to treat serious diseases when used with the Zapper.

The FTC charged that the defendants did not have a reasonable basis to substantiate the claims made in the ads.

To settle the FTC’s charges, the proposed final order prohibits the defendants from making unsubstantiated health or safety claims for any food, drug, dietary supplement, or device. The order also requires the defendants to notify US consumers that they are entitled to full refunds. In addition, the settlement contains various recordkeeping provisions to assist the FTC in monitoring the defendants’ compliance.

The Commission vote authorizing staff to file the settlement in federal district court was 5-0. It was filed in the US District Court for the Northern District of Ohio, Eastern Division, on November 18, 2004, and entered by the court on November 22, 2004.

Related Document

This page was posted on October 10, 2005.